| Sai Parenteral's Ltd |
|---|
| Registered Office: No.39 5th Flr Lavanya Arcade-, Jayabheri Enclave Gachibowli, Rangareddy - 500032, Telangana |
| Phone: +91 79979 91301 |
| Email: cs@saiparenterals.com |
| Website: https://www.saiparenterals.com |
| Initial public offer of up to 10428288 equity shares of face value of Rs. 5 each ("Equity Shares") of Sai Parenteral's Limited ("Company" or "Issuer") for cash at a price of Rs. 392 per equity share (Including a Share Premium of Rs. 387 Per Equity Share) ("Offer Price") aggregating up to Rs. 408.79 Crore comprising a fresh issue of up to 7270408 equity shares of face value of Rs. 5 each aggregating up to Rs. 285 Crore by the company ("Fresh Issue") and an offer for sale of up to 3,157,880 equity shares of face value of Rs. 5 each aggregating up to Rs. 123.79 Crore ("Offered Shares") by investor selling shareholders (such sale, the "Offer For Sale", and together with the fresh issue, the"Offer"). The offer shall constitute [*]% of the post-offer paid up equity share capital of the company. Price Band: Rs. 392 per equity share of face value of Rs. 5 each. The floor price is 78.40 times the face value of the equity shares. Bids can be made for a minimum of 38 equity shares of face value of Rs. 5 each and in multiples of 38 equity shares of face value of Rs. 5 each thereafter. |
| Issue | Money Payable On | ||
|---|---|---|---|
| Opens On | Closes On | Application | Allotment |
| 24-Mar-2026 | 27-Mar-2026 | ₹ 392.00 | ₹ 0.00 |
| Minimum Application for shares in Nos : 38.0 Further Multiples of : 38.0 | ||
|---|---|---|
| (₹)Cr. | Lead Managers to the Issue | |
| Project Cost | 0.00 | Arihant Capital Markets Limited |
| Project Financed through Current Offer | 408.79 | |
| Post Issue Equity Share Capital | 23.67 | |
| Issue Price | ₹392.00 | |
| Projects |
|---|
| Capacity expansion and upgradation of manufacturing facilities |
| Establishment of a new R&D Centre |
| Repayment / prepayment of certain outstanding borrowings |
| Working capital requirements |
| Investment in wholly owned subsidiary, Sai Parenterals Pte Limited (Singapore), in relation to the proposed acquisition of Noumed Pharmaceuticals Pty Limited (Australia) |
| General corporate purposes |
| Promoted By |
|---|
| Anil Kumar Karusala |
| Vijitha Gorrepati |
| Karusala Aruna |
| Listing At |
|---|
| BSE |
| NSE |
| Registrar to the Issue |
|---|
